FR2691066B1 - Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies. - Google Patents

Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.

Info

Publication number
FR2691066B1
FR2691066B1 FR9205949A FR9205949A FR2691066B1 FR 2691066 B1 FR2691066 B1 FR 2691066B1 FR 9205949 A FR9205949 A FR 9205949A FR 9205949 A FR9205949 A FR 9205949A FR 2691066 B1 FR2691066 B1 FR 2691066B1
Authority
FR
France
Prior art keywords
thrombopenia
medicaments
analogs
fractions
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9205949A
Other languages
English (en)
Other versions
FR2691066A1 (fr
Inventor
Han Zhong Chao
Caen Jacques
Lormeau Jean-Claude
Petitou Maurice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elf Sanofi SA
IVS Institut des Vaisseaux et du Sang
Original Assignee
Elf Sanofi SA
IVS Institut des Vaisseaux et du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elf Sanofi SA, IVS Institut des Vaisseaux et du Sang filed Critical Elf Sanofi SA
Priority to FR9205949A priority Critical patent/FR2691066B1/fr
Priority to PCT/FR1993/000458 priority patent/WO1993023059A1/fr
Priority to JP5519938A priority patent/JPH07506584A/ja
Priority to EP93910111A priority patent/EP0641213A1/fr
Publication of FR2691066A1 publication Critical patent/FR2691066A1/fr
Application granted granted Critical
Publication of FR2691066B1 publication Critical patent/FR2691066B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9205949A 1992-05-15 1992-05-15 Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies. Expired - Fee Related FR2691066B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR9205949A FR2691066B1 (fr) 1992-05-15 1992-05-15 Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.
PCT/FR1993/000458 WO1993023059A1 (fr) 1992-05-15 1993-05-11 Utilisation de glycosaminoglycanes exogenes ou derives dans le traitement des thrombopenies
JP5519938A JPH07506584A (ja) 1992-05-15 1993-05-11 血小板減少症治療における外因性グリコサミノグリカン類または誘導体の利用
EP93910111A EP0641213A1 (fr) 1992-05-15 1993-05-11 Utilisation de glycosaminoglycanes exogenes ou derives dans le traitement des thrombopenies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9205949A FR2691066B1 (fr) 1992-05-15 1992-05-15 Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.

Publications (2)

Publication Number Publication Date
FR2691066A1 FR2691066A1 (fr) 1993-11-19
FR2691066B1 true FR2691066B1 (fr) 1995-06-09

Family

ID=9429842

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9205949A Expired - Fee Related FR2691066B1 (fr) 1992-05-15 1992-05-15 Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.

Country Status (4)

Country Link
EP (1) EP0641213A1 (fr)
JP (1) JPH07506584A (fr)
FR (1) FR2691066B1 (fr)
WO (1) WO1993023059A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646130A (en) * 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
WO1997025051A1 (fr) * 1996-01-11 1997-07-17 Hyal Pharmaceutical Corporation Administration orale de quantites efficaces de formes de l'acide hyaluronique
AU4938397A (en) * 1996-12-24 1998-07-17 Hyal Pharmaceutical Corporation Methods of elevating amounts of hyaluronan in the human body
US6593310B1 (en) * 2000-11-21 2003-07-15 Arthropharm Pty. Ltd. Treatment of osteoporosis
JP2005187435A (ja) * 2003-12-26 2005-07-14 Otsuka Chemical Co Ltd 血小板産生促進組成物
FR3144752A1 (fr) 2023-01-10 2024-07-12 Song Huang Utilisation de polysulfate de pentosane pour le traitement de la toux seche

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3466365A (en) * 1967-07-24 1969-09-09 White Lab Inc Antiviral compositions and method of use
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4258034A (en) * 1979-11-05 1981-03-24 American Cyanamid Company Lactobionic acid poly(H-sulfate) and salts thereof useful as complement inhibitors
DE3441835A1 (de) * 1984-11-15 1986-05-22 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Blutstillungsmittel
IT1208509B (it) * 1985-03-13 1989-07-10 Mediolanum Farmaceutici Srl Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.
FR2597484B1 (fr) * 1986-04-17 1988-12-23 Sanofi Sa Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
ZA878877B (en) * 1986-11-29 1988-05-24 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of diseases caused by viruses
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
EP0504361A4 (en) * 1990-10-05 1994-08-17 Systemix Inc Megakaryocyte and platelet growth, production and composition

Also Published As

Publication number Publication date
WO1993023059A1 (fr) 1993-11-25
FR2691066A1 (fr) 1993-11-19
EP0641213A1 (fr) 1995-03-08
JPH07506584A (ja) 1995-07-20

Similar Documents

Publication Publication Date Title
MX9203026A (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,5-tieno (3,2-c) piridil-5) (cloro-2 fenil)-acetato de metilo y composiciones farmaceuticas que lo contienen.
IT8547852A0 (it) Ciclosporine,processi per la loro preparazione,uso farmaceutico delle stesse e composizioni farmaceutiche che le contengono
FR2662354B1 (fr) Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine.
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
IT8214741V0 (it) Lampada lanciabile per consentire, da posizioni di sicurezza, una visione immediata dell'ambiente edi chi lo occupa, come preliminare ad operazioni di rischio
EP1157698A3 (fr) Traitement des maladies inflammatoires avec des nucleosides a base d'oxypurine
IL90551A (en) Stable, injectable, aqueous pharmaceutical compositions for the treatment of cardiac conditions
IT8119673A0 (it) Composizioni farmaceutiche per il trattamento di osteopatie.
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
FR2691066B1 (fr) Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.
AU8732182A (en) Pharmaceutical compositions for the treatment of skin
MC1878A1 (fr) Compositions pharmaceutiques
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
IT8319600A0 (it) Composizioni farmaceutiche e loro uso nel trattamento del glaucoma.
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
IT8467291A0 (it) Composizione farmaceutica per rinforzare i vasi sanguigni
ITMI941846A0 (it) Processo per la preparazione del gestodene
IT8619086A0 (it) Composizioni farmaceutiche comprendenti frammenti di acth per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
MA21630A1 (fr) Compositions pour le traitement de leishmanioses .
SE8804317D0 (sv) Kompositioner foer reduktion av flebektasi jaemte foerfarande foer framstaellning av dessa
IT8520440A0 (it) Derivati del pirano, loro preparazione e composizioni terapeutiche contenenti glistessi

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse